Anatara Lifesciences Ltd (ASX:ANR) Directors Insider Transactions



The Directors and Chief Executives of Anatara Lifesciences Ltd (ASX:ANR) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Anatara Lifesciences Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Anatara Lifesciences Ltd to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Anatara Lifesciences Ltd Directors/Insider Transactions Activity

List of Insider trades activity from Anatara Lifesciences Ltd (ANR).

Date Director Director's Title Shares Value Note
26 Nov 2025 Brookes (David Lionel) Executive Chairman 3,333,334 26,000 Other at price 0.01 per share.
26 Nov 2025 van Dissel (Dirk) Director (Non-Executive) 3,333,333 25,999 Other at price 0.01 per share.
23 Dec 2024 Brookes (David Lionel) Executive Chairman 500,000 15,600 Other at price 0.03 per share.
23 Dec 2024 Michailidis (John) Director (Non-Executive) 100,000 3,120 Other at price 0.03 per share.
09 Jul 2024 Brookes (David Lionel) Executive Chairman 1,500,000 40,350 Other at price 0.03 per share.
09 Jul 2024 Michailidis (John) Director (Non-Executive) 250,000 6,725 Other at price 0.03 per share.